Title | Type | SJR | H index | Total Docs. (2009) | Total Docs. (3years) | Total Refs. (2009) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2009) | %Female (2009) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | European Neuropsychopharmacology | journal | 1.309 Q1 | 130 | 110 | 313 | 5066 | 1113 | 306 | 3.53 | 46.05 | 37.67 | |
52 | Pharmacology Biochemistry and Behavior | journal | 1.309 Q1 | 148 | 255 | 688 | 13572 | 2102 | 684 | 3.13 | 53.22 | 39.38 | |
53 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | journal | 1.291 Q1 | 150 | 288 | 846 | 12937 | 2409 | 721 | 2.77 | 44.92 | 36.76 | |
54 | Toxicology and Applied Pharmacology | journal | 1.290 Q1 | 189 | 320 | 933 | 16671 | 3525 | 917 | 3.77 | 52.10 | 40.93 | |
55 | Pharmaceutical Statistics | journal | 1.283 Q1 | 46 | 32 | 90 | 745 | 133 | 79 | 1.59 | 23.28 | 19.57 | |
56 | Cancer Biology and Therapy | journal | 1.280 Q1 | 130 | 370 | 993 | 13363 | 2380 | 759 | 2.28 | 36.12 | 37.83 | |
57 | Expert Review of Vaccines | journal | 1.278 Q1 | 105 | 156 | 310 | 11295 | 1142 | 276 | 3.97 | 72.40 | 37.27 | |
58 | Antiviral Research | journal | 1.277 Q1 | 151 | 132 | 369 | 6144 | 1570 | 367 | 4.14 | 46.55 | 38.12 | |
59 | Current Opinion in Investigational Drugs | journal | 1.276 Q1 | 83 | 136 | 371 | 9871 | 1308 | 339 | 3.66 | 72.58 | 25.88 | |
60 | Expert Opinion on Investigational Drugs | journal | 1.251 Q1 | 117 | 165 | 481 | 12080 | 1956 | 449 | 4.54 | 73.21 | 28.29 | |
61 | Current Opinion in Molecular Therapeutics | journal | 1.249 Q1 | 67 | 77 | 212 | 5421 | 730 | 194 | 3.72 | 70.40 | 27.56 | |
62 | Journal of Clinical Pharmacology | journal | 1.235 Q1 | 130 | 142 | 454 | 4013 | 1688 | 432 | 3.88 | 28.26 | 33.91 | |
63 | Current Drug Metabolism | journal | 1.223 Q1 | 122 | 90 | 255 | 12668 | 1277 | 245 | 4.44 | 140.76 | 41.06 | |
64 | ChemMedChem | journal | 1.205 | 119 | 218 | 530 | 9458 | 1780 | 522 | 3.35 | 43.39 | 35.49 | |
65 | Advances in Pharmacology | journal | 1.198 Q1 | 86 | 14 | 73 | 1944 | 220 | 68 | 3.81 | 138.86 | 15.00 | |
66 | Cardiovascular Drugs and Therapy | journal | 1.194 Q1 | 79 | 70 | 184 | 2583 | 434 | 149 | 2.24 | 36.90 | 27.10 | |
67 | British Journal of Clinical Pharmacology | journal | 1.187 Q1 | 167 | 216 | 725 | 6383 | 2305 | 558 | 3.02 | 29.55 | 34.18 | |
68 | PharmacoEconomics | journal | 1.186 Q1 | 118 | 90 | 305 | 3575 | 816 | 244 | 2.63 | 39.72 | 31.54 | |
69 | Investigational New Drugs | journal | 1.146 Q1 | 97 | 73 | 202 | 2268 | 604 | 201 | 3.21 | 31.07 | 37.86 | |
70 | Naunyn-Schmiedeberg's Archives of Pharmacology | journal | 1.142 Q1 | 99 | 119 | 303 | 4882 | 889 | 296 | 2.95 | 41.03 | 37.80 | |
71 | Expert Opinion on Biological Therapy | journal | 1.137 Q1 | 102 | 141 | 454 | 11591 | 1569 | 448 | 3.57 | 82.21 | 34.91 | |
72 | BioDrugs | journal | 1.124 Q1 | 79 | 35 | 126 | 2782 | 442 | 117 | 4.24 | 79.49 | 38.36 | |
73 | Cancer Chemotherapy and Pharmacology | journal | 1.088 Q1 | 122 | 293 | 683 | 9069 | 1968 | 673 | 2.89 | 30.95 | 33.78 | |
74 | Journal of Ethnopharmacology | journal | 1.085 Q1 | 231 | 481 | 1304 | 17466 | 4281 | 1290 | 2.89 | 36.31 | 38.55 | |
75 | Journal of Pharmacological Sciences | journal | 1.081 Q2 | 101 | 199 | 557 | 6895 | 1539 | 551 | 2.39 | 34.65 | 26.96 | |
76 | Clinical Therapeutics | journal | 1.079 Q2 | 150 | 287 | 764 | 9619 | 2802 | 695 | 3.38 | 33.52 | 35.34 | |
77 | Journal of Pharmacokinetics and Pharmacodynamics | journal | 1.077 Q2 | 70 | 32 | 103 | 869 | 241 | 101 | 2.25 | 27.16 | 34.78 | |
78 | Journal of Biomolecular Screening | journal | 1.067 Q2 | 86 | 117 | 306 | 2914 | 820 | 304 | 2.56 | 24.91 | 30.22 | |
79 | Journal of Cardiovascular Pharmacology | journal | 1.063 Q2 | 109 | 146 | 509 | 6660 | 1544 | 495 | 3.13 | 45.62 | 28.47 | |
80 | Pharmacogenomics | journal | 1.051 Q2 | 100 | 184 | 468 | 8961 | 1614 | 412 | 3.35 | 48.70 | 38.72 | |
81 | Vascular Pharmacology | journal | 1.049 Q2 | 108 | 79 | 272 | 3287 | 744 | 266 | 2.18 | 41.61 | 35.37 | |
82 | European Journal of Pharmacology | journal | 1.048 Q2 | 203 | 601 | 2382 | 26542 | 7262 | 2376 | 2.91 | 44.16 | 35.05 | |
83 | Prostaglandins and Other Lipid Mediators | journal | 1.047 Q2 | 86 | 58 | 165 | 2772 | 429 | 163 | 2.74 | 47.79 | 38.58 | |
84 | Chirality | journal | 1.040 Q2 | 83 | 150 | 347 | 6302 | 874 | 342 | 2.71 | 42.01 | 33.56 | |
85 | Drug Metabolism and Pharmacokinetics | journal | 0.981 Q2 | 75 | 72 | 185 | 2621 | 574 | 175 | 2.70 | 36.40 | 28.33 | |
86 | Chemical Biology and Drug Design | journal | 0.964 | 91 | 148 | 336 | 5442 | 900 | 325 | 2.52 | 36.77 | 35.11 | |
87 | European Journal of Medicinal Chemistry | journal | 0.964 Q2 | 203 | 624 | 656 | 22026 | 2302 | 656 | 3.44 | 35.30 | 38.80 | |
88 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.951 Q2 | 100 | 125 | 259 | 11138 | 976 | 253 | 3.57 | 89.10 | 30.62 | |
89 | Anti-Cancer Drugs | journal | 0.941 Q2 | 102 | 132 | 434 | 4194 | 1190 | 431 | 2.62 | 31.77 | 37.27 | |
90 | Cardiovascular Therapeutics | journal | 0.927 Q2 | 54 | 37 | 32 | 1698 | 93 | 28 | 2.91 | 45.89 | 21.85 | |
91 | Microbial Drug Resistance | journal | 0.915 Q2 | 78 | 51 | 134 | 1183 | 293 | 134 | 2.08 | 23.20 | 47.37 | |
92 | Inflammation and Allergy - Drug Targets | journal | 0.911 Q2 | 55 | 51 | 97 | 3969 | 285 | 92 | 3.02 | 77.82 | 28.92 | |
93 | Steroids | journal | 0.907 Q2 | 114 | 144 | 423 | 5192 | 1194 | 419 | 3.16 | 36.06 | 42.70 | |
94 | Phytomedicine | journal | 0.890 Q2 | 141 | 158 | 427 | 4522 | 1273 | 414 | 2.81 | 28.62 | 38.03 | |
95 | Bulletin of Mathematical Biology | journal | 0.884 Q2 | 97 | 87 | 324 | 3457 | 657 | 321 | 2.07 | 39.74 | 22.27 | |
96 | Clinical and Experimental Pharmacology and Physiology | journal | 0.873 Q2 | 115 | 199 | 712 | 8256 | 1723 | 691 | 2.10 | 41.49 | 35.48 | |
97 | Xenobiotica | journal | 0.865 Q2 | 89 | 100 | 252 | 3638 | 745 | 249 | 3.07 | 36.38 | 30.09 | |
98 | Expert Opinion on Emerging Drugs | journal | 0.863 Q2 | 54 | 45 | 134 | 5224 | 386 | 134 | 3.00 | 116.09 | 26.23 | |
99 | Therapeutic Drug Monitoring | journal | 0.858 Q2 | 102 | 99 | 384 | 3775 | 1060 | 360 | 2.73 | 38.13 | 36.67 | |
100 | Clinical Neuropharmacology | journal | 0.856 Q2 | 85 | 97 | 179 | 2350 | 507 | 165 | 2.80 | 24.23 | 33.43 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®